Cogent Biosciences, Inc. - Common Stock, $0.001 par value per share (COGT)

CUSIP: 19240Q201

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / Common Stock, $0.001 par value per share
Shares outstanding
155,716,944
Total 13F shares
121,716,056
Share change
-1,028,468
Total reported value
$949,488,255
Put/Call ratio
285%
Price per share
$7.80
Number of holders
173
Value change
-$21,661,319
Number of buys
85
Number of sells
69

Quarterly Holders Quick Answers

What is CUSIP 19240Q201?
CUSIP 19240Q201 identifies COGT - Cogent Biosciences, Inc. - Common Stock, $0.001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Cogent Biosciences, Inc. - Common Stock, $0.001 par value per share (COGT) as of Q4 2024

As of 31 Dec 2024, Cogent Biosciences, Inc. - Common Stock, $0.001 par value per share (COGT) was held by 173 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 121,716,056 shares. The largest 10 holders included FMR LLC, Kynam Capital Management, LP, BlackRock, Inc., TCG Crossover Management, LLC, COMMODORE CAPITAL LP, Fairmount Funds Management LLC, VANGUARD GROUP INC, VR Adviser, LLC, Point72 Asset Management, L.P., and Paradigm Biocapital Advisors LP. This page lists 174 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.